ETF comparison

IBBvsXBI

Both Healthcare.

iShares Biotechnology ETF · State Street SPDR S&P Biotech ETF

Holdings overlap

Weighted by ISIN/CUSIP
41.6%

123 positions appear in both funds. Buying equal dollars of IBB and XBI would leave roughly41.6%of each dollar exposed to the same underlying securities.

IBB only 70.3%Shared 41.6%XBI only 58.3%
In IBB only
127 positions
Shared
123 positions
In XBI only
34 positions

Side by side

IBB

iShares Biotechnology ETF

iShares · Healthcare

70composite / 100
Expense ratio
0.44%
Net assets
$10.47B
TTM yield
0.20%
Top-10 conc.
54.3%
XBI

State Street SPDR S&P Biotech ETF

State Street · Healthcare

81composite / 100
Expense ratio
0.35%
Net assets
$11.40B
TTM yield
0.36%
Top-10 conc.
18.0%

Sub-score comparison

56
Cost
65
85
Tax efficiency
85
100
Liquidity
100
37
Concentration
89
Tracking quality
IBBsub-scoreXBI

Tracking quality isn't part of the composite — seewhat we don't scorefor why.

Cost difference

XBI is 9 bps cheaper than IBB. On a $100,000 position that's about $90/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open thecost calculator pre-filled with IBB vs XBI.

Top shared holdings

123 shared in total
#HoldingIn IBBIn XBIOverlap
1Moderna, Inc.1.98%1.41%1.41%
2Revolution Medicines, Inc.2.78%1.20%1.20%
3Natera, Inc.2.89%1.16%1.16%
4Roivant Sciences Ltd.1.43%1.16%1.16%
5Insmed, Inc.1.78%1.08%1.08%
6Vertex Pharmaceuticals, Inc.8.08%1.06%1.06%
7Biogen, Inc.2.47%1.03%1.03%
8Ionis Pharmaceuticals, Inc.1.00%1.00%1.00%
9Incyte Corp.1.75%1.00%1.00%
10Amgen, Inc.7.83%0.99%0.99%
11Bridgebio Pharma, Inc.0.98%1.02%0.98%
12Neurocrine Biosciences, Inc.1.30%0.97%0.97%

Only in IBB

127 total
  • BlackRock Funds III11.66%
  • Argenx SE3.76%
  • Illumina, Inc.2.07%
  • BeOne Medicines Ltd.1.77%
  • Ascendis Pharma A/S1.29%
  • Genmab A/S1.12%
  • Medpace Holdings, Inc.0.95%
  • Bio-Techne Corp.0.86%
  • Charles River Laboratories International, Inc.0.84%
  • Axsome Therapeutics, Inc.0.82%

Only in XBI

34 total
  • Viking Therapeutics Inc1.30%
  • SELLAS Life Sciences Group Inc1.19%
  • Dianthus Therapeutics Inc1.18%
  • Celcuity Inc1.10%
  • TG Therapeutics Inc1.09%
  • AbbVie Inc1.04%
  • Catalyst Pharmaceuticals Inc0.87%
  • Celldex Therapeutics Inc0.70%
  • Viridian Therapeutics Inc0.67%
  • Immunome Inc0.59%

Open IBB or XBI at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodologyand funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see/methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.